Patent details

EP3344251 Title: A COMBINATION THERAPY COMPRISING VARLITINIB AND AN ANTICANCER AGENT

Basic Information

Publication number:
EP3344251
PCT Application Number:
EP2016070888
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP167744580
PCT Publication Number:
WO2017037298
First applicant's nationality:
Translation Language:
EPO Publication Language:
English Title of Invention:
A COMBINATION THERAPY COMPRISING VARLITINIB AND AN ANTICANCER AGENT
French Title of Invention:
COMBINAISON COMPRENANT DU VARLITINIB ET UN AGENT ANTI-CANCÉREUX
German Title of Invention:
KOMBINATION ENTHALTEND VARLITINIB UND EIN ANTI-KREBS MITTEL
SPC Number:

Dates

Filing date:
05/09/2016
Grant date:
28/04/2021
EP Publication Date:
11/07/2018
PCT Publication Date:
09/03/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/04/2021
EP B1 Publication Date:
28/04/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/09/2021
Expiration date:
05/09/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/04/2021
 
 

Name:
Aslan Pharmaceuticals PTE Limited
Address:
10-A Bukit Pasoh Road, 089824, Singapore (SG)

Inventor

1

Name:
LINDMARK, Bertil
Address:
Singapore (SG)

2

Name:
OOI, Lisa
Address:
Singapore (SG)

Priority

1

Priority Number:
201515712
Priority Date:
04/09/2015
Priority Country:
United Kingdom (GB)

2

Priority Number:
201515716
Priority Date:
04/09/2015
Priority Country:
United Kingdom (GB)

3

Priority Number:
201515718
Priority Date:
04/09/2015
Priority Country:
United Kingdom (GB)

4

Priority Number:
201515714
Priority Date:
04/09/2015
Priority Country:
United Kingdom (GB)

5

Priority Number:
201562217346 P
Priority Date:
11/09/2015
Priority Country:
United States (US)

6

Priority Number:
201562217332 P
Priority Date:
11/09/2015
Priority Country:
United States (US)

7

Priority Number:
201605583
Priority Date:
01/04/2016
Priority Country:
United Kingdom (GB)

8

Priority Number:
201608660
Priority Date:
17/05/2016
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 31/51; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202117
Publication date:
28/04/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages